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introduction of newer agents (levofloxacin in 2001
and moxifloxacin in 2002).
Rates of resistance decline appear to be slower
than rates of resistance emergence, and appear to
vary with different classes of agent. Appropriate
use of antimicrobial agents appears to be the most
important factor in limiting the spread of drug
resistance among pneumococci. In Taiwan, the
decreasing selective pressure for resistance, associ-
ated with a government policy of restricting anti-
biotic use for acute respiratory tract infections
without evidence of bacterial involvement, has
resulted in a decline in erythromycin resistance in
Streptococcuspyogenes [8] andinpenicillin resistance
in pneumococci; however, the impact of this policy
on macrolide resistance in S. pneumoniae is not yet
clear. The present results indicate that continuous
enforcement of the policy to limit use of antimicro-
bial agents is warranted. Such programmes may
protect the effectiveness of newer antimicrobial
agents and limit the emergence of resistance. Active
surveillance of antimicrobial resistance through a
nationwide system, and use of better anti-pneumo-
coccal vaccines, are also required.
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In total, 124 Streptococcus pyogenes isolates were
obtained from throat cultures of different symp-
tomatic patients. All isolates showed M-pheno-
type macrolide resistance and contained the
macrolide efflux gene mef(A). The isolates were
screened for the presence and insertion site of
mef(A)-containing genetic elements. In 25.8% of
the isolates, mef(A) was found to be carried by
elements belonging to the Tn1207.3 ⁄ F10394.4
family inserted in the comEC gene, while 74.2%
contained chimeric elements with a different
genetic structure and chromosomal location,
probably associated with the recently described
60-kb tet(O)–mef(A) element.
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The acquisition of erythromycin resistance by
group A streptococci (Streptococcus pyogenes) is
associated frequently with an efflux system that
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results in a resistance pattern referred to as
M-phenotype (resistance to 14- and 15-membered
macrolides; sensitivity to lincosamides and strep-
togramin B) [1,2]. The mef(A) gene is the genetic
determinant of this resistance mechanism and is
carried by genetic elements shown recently to be
chimeric in nature, i.e., composed of a mef(A)-
carrying transposon inserted into a functional
prophage [3–5]. Three related genetic structures
have been described: Tn1207.3 [6], F10394.4 [7],
and the recently characterised tet(O)–mef(A) ele-
ment [8]. The size of these elements ranges from
52 to 60 kb, and while the chromosomal insertion
site of Tn1207.3 ⁄ F10394.4 has been mapped to the
comEC gene [5,6], the tet(O)–mef(A) element is
integrated at various chromosomal locations [4,8].
The present study analysed the general structure
and chromosomal insertion site of these genetic
elements in 124 S. pyogenes clinical isolates collec-
ted from several Italian laboratories between 1997
and 1998 in the context of a nationwide survey of
pharyngotonsillitis in paediatric patients.
All isolates were resistant to erythromycin and
displayed an efflux-mediated M-phenotype with
low-level resistance (MIC 1–8 mg ⁄L), as assessed
by the double-disk test [1]. A set of oligonucleo-
tide primers was constructed using Primer3 soft-
ware (http://frodo.wi.mit.edu/cgi-bin/primer3/
primer3_http://www.cgi) and was used in PCR
experiments to screen for the presence of distinc-
tive elements along the entire sequence of the
three chimeric mef(A)-containing elements
(Fig. 1). All PCRs were run for 30 cycles in a final
volume of 25 lL and contained 0.5 lg of chromo-
somal DNA, 10 mM Tris-HCl (pH 8.3), 50 mM
KCl, 1.25 mM MgCl2, 100 lM dNTPs, 1 lM
oligoprimers and 1 U of AmpliTaq Gold poly-
merase (Applied Biosystems, Warrington, UK).
Annealing conditions are listed in the footnote to
Table 1. Agarose 2% w ⁄ v gel electrophoresis was
used to analyse the amplification products.
Amplicon A (intact form of comEC) was
detected using forward primer MS54 [6] and
(1818)-5¢-GCTGGAGACCAGTTGCCTATTATGG-
G-3¢-(1844) (comEC, accession no. AE006577) as
the reverse primer. Amplicon B (left junction
insertion of Tn1207.3 in comEC) was detected
using MS54 and (203)-5¢-GATAGGGTTTATGC-
GGCGAAGACTCCTGAG-3¢-(233) (accession no.
AY657002). Product G (right junction insertion of
Tn1207.3 ⁄ F10394.4 in comEC) was detected
using (58461)-5¢-CGAGGAGTTAGTATGGAAA-
C-3¢-(58481) (accession no. AY445042) and
(1818)-5¢-GCTGGAGACCAGTTGCCTATTATGG-
G-3¢-(1844) (comEC; accession no. AE006577).
ABC transporter (amplicon D), umuC–mucB
(amplicon E), type II modification methylase
(amplicon F) and R-28-like (amplicon H) genes
were internal to transposon F10394.4 (acces-
sion no. AY445042) and were detected using
the following primers: for (D), (11581)-5¢-GCAG-
CCCTTTCCAATCG-3¢-(11597) and (11178)-5¢-
GGACGAAGTAACTCTGCAGG-3¢-(11197); for
(E), (13408)-5¢-CGTCATGAGCCGTGCAGACA-
ACTCGG-3¢-(13434) and (14459)-5¢-GCCACCA
TAAGACACACCGATTTGCC-3¢-(14476); for (F),
(15861)-5¢-CCGGAATTATAAACTCTTCAGGG-
3¢-(15883) and (16158)-5¢-GTGAATTCCGTTT-
CCCTGAACCG-3¢-(16181); and for (H), (1921)-
5¢-CGGTGAGATTGGCGGAG-3¢-(1937) and (2581)-
5¢-GCTTCTTCTGCTTGCTTCTCG-3¢-(2601). The
mef(A) and tet(O) genes were detected using
the primers described by Sutcliffe et al. [9] and
Olsvik et al. [10], respectively.
All isolates tested were positive for mef(A)
(amplicon C; Table 1) and the ABC transporter
gene (amplicon D). The latter gene has also been
described in Streptococcus pneumoniae, where it is
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Fig. 1. Schematic representation of the genetic element
structures known to be vectors of mef(A). 1, 2 and 3 depict
the forms of the chimeric genetic elements: Tn1207.3,
F10394.4 and tet(O)–mef(A), respectively. The approximate
localisations of the sequences amplified by PCR are shown
as boxes labelled with a capital letter (see Table 1 for full
description). The comEC, tet(O) and mef(A) genes are also
shown.
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referred to as msr(D) and is always associated
with mef(A) [11]. In S. pyogenes, the msr-like
homologue seems to be necessary for proper
expression of the macrolide resistance phenotype
[12]. Two variants of the mef gene have been
described in streptococci, mef(A) and mef(E)
[13,14]. In order to discriminate between mef(A)
and mef(E), PCR–restriction fragment length poly-
morphism analysis was performed as described
previously [15]. Only the mef(A) subclass was
found (data not shown).
Most (83.9%) of the population contained the
intact form of comEC, while comEC was not
amplified from the remaining 16.1%. The latter
result was associated with insertion of
Tn1207.3 ⁄ F10394.4-related chimeric elements into
comEC itself, as confirmed by amplification of the
downstream insertion point flanking region
(amplicon G) and of products E and F (Fig. 1)
[5]. In a subgroup of Tn1207.3-positive isolates
(n = 12), amplification of comEC (amplicon A) was
also obtained (Table 1). This result was unex-
pected, since both the intact form of comEC and
form 1 of the chimeric genetic elements (Fig. 1)
co-existed. To rule out the possibility of false-
positive results, three random isolates belonging
to this latter group were selected and their A and
G amplification products were sequenced. The
results confirmed that the product A sequence
corresponded to uninterrupted comEC, while
product G resulted from amplification of the
junction between the 3¢-prophage end and comEC.
Possible explanations for this finding might
involve errors occurring during the phage repli-
cation cycle, or duplication of flanking regions in
the course of homologous recombination events.
Amplification of products B and H (Table 1;
Fig. 1) was designed to discriminate between
Tn1207.3 and F10394.4. Amplification of the
comEC–Tn1207.1 left junction (amplicon B;
Fig. 1) was obtained with 26 of 32
Tn1207.3 ⁄ F10394.4-positive isolates. Product H,
amplified from a region of DNA internal to the
R-6 (R-28-like) gene contained in F10394.4 [5]
(Fig. 1, form 3), was observed with six of 32
Tn1207.3 ⁄ F10394.4-positive isolates (Table 1).
In total, 86 isolates were negative for
Tn1207.3 ⁄ F10394.4 and were resistant to tetracyc-
line, as assessed by the standard agar disk-
diffusion test [16]. In this latter group, the ampli-
fication of product J identified tet(O) as the genetic
determinant of the tetracycline resistance (Fig. 1,
form 3). Therefore, the general pattern shown by
this large group of isolates is compatible with the
presence of the tet(O)–mef(A) element. Finally, six
isolates showed a PCR pattern that did not
correspond to any of the three elements described
so far. The possibility of novel mef(A)-containing
genetic elements is currently being investigated.
In summary, the S. pyogenes isolates studied
showed an interesting pattern of mef(A)-contain-
ing genetic element variability, providing addi-
tional confirmation of the continuous evolution of
antibiotic resistance in this group of bacteria, and
demonstrating the importance of monitoring anti-
biotic-resistant bacterial populations from differ-
ent standpoints, including surveying the presence
of genetic elements involved in the exchange of
genetic material between microorganisms. More-
over, prophage-related open reading frames,
although forming a small part of the total genome,
are responsible for up to 75% of the variations in
gene content between different isolates, and have
contributed significantly to the evolution of group
A streptococci [17,18].
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Table 1. PCR-based detection of genes and sequences associated with mef(A)-containing chimeric elements.
Prophage detected Chromosomal location
Amplicon namea
% of positive isolatesA B C D E F G H J
Tn1207.3 comEC – + + + + + + – – 11.29
Other + + + + + + + – – 9.68
F10394.4 comEC – – + + + + + + – 4.84
tet(O)–mef(A) Other + – + + – – – – + 69.35
95.16
aThe relative positions of amplification products on the structures of the genetic elements are shown in Fig. 1. Thermal cycling conditions (annealing time and temperature)
were as follows: for amplicons A, B, F and G, 60C for 40 s; for D, 57C for 40 s; for H, 57C for 60 s; for C, 53C for 60 s; and for E, 68C for 60 s. The annealing conditions for
tet(O) were 50C for 40 s.
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In total, 309 blood culture supernatants were
tested for the presence of Burkholderia pseudomallei
antigen using an in-house coagglutination test
prepared by sensitising Cowan I staphylococcal
cells with B. pseudomallei polyclonal antiserum.
The coagglutination test gave a sensitivity, spe-
cificity, positive predictive value and negative
predictive value of 100% in comparison with
blood culture. A subset of 102 supernatants was
also tested for B. pseudomallei antigen using a
monoclonal antibody-based latex agglutination
test. The sensitivity, specificity, positive predic-
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